CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-05 | Ekman Lars Director | Sale | −6,400 | $18.00 | $115K | 0 |
| 2019-09-03 | Ekman Lars Director | Sale | −91,016 | $15.01 | $1.4M | 0 |
| 2019-07-11 | STACK DAVID M Director | Sale | −51,991 | $22.28 | $1.2M | 0 |
| 2019-07-05 | Zakrzewski Joseph S Director | Sale | −100,000 | $23.82 | $2.4M | 84,547 |
| 2019-07-03 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −29,250 | $22.64 | $662K | 36,351 |
| 2019-07-02 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −50,000 | $20.46 | $1.0M | 55,915 |
| 2019-07-02 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −19,564 | $21.42 | $419K | 36,351 |
| 2019-07-01 | Kennedy Joseph T General Counsel | Sale | −54,186 | $19.52 | $1.1M | 31,260 |
| 2019-07-01 | Kalb Michael Wayne SVP and CFO | Sale | −50,000 | $19.67 | $983K | 20,840 |
| 2019-06-24 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −113,195 | $18.59 | $2.1M | 36,351 |
| 2019-06-18 | Zakrzewski Joseph S Director | Sale | −100,000 | $19.02 | $1.9M | 84,547 |
| 2019-05-31 | Kennedy Joseph T General Counsel | Sale | −27,229 | $17.92 | $488K | 31,260 |
| 2019-05-29 | STACK DAVID M Director | Sale | −33,799 | $18.45 | $624K | 0 |
| 2019-05-17 | STACK DAVID M Director | Sale | −13,174 | $18.00 | $237K | 0 |
| 2019-04-30 | Ketchum Steven B Chief Scientific Officer | Sale | −9,541 | $18.67 | $178K | 354,492 |
| 2019-04-30 | Kennedy Joseph T General Counsel | Sale | −27,230 | $18.69 | $509K | 31,260 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Sale | −9,442 | $20.05 | $189K | 354,592 |
| 2019-04-01 | Ketchum Steven B Chief Scientific Officer | Sale | −100 | $20.78 | $2K | 354,492 |
| 2019-04-01 | Kennedy Joseph T General Counsel | Sale | −53,060 | $20.03 | $1.1M | 32,372 |
| 2019-04-01 | Kennedy Joseph T General Counsel | Sale | +1,112 | $20.80 | $23K | 31,260 |
Page 2 of 7 · 123 trades